| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.6 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |